180 related articles for article (PubMed ID: 38107298)
1. Comparison of two different TSH-receptor antibody assays: A clinical practice study.
van Balkum M; Schreurs MWJ; Visser WE; Peeters RP; Dik WA
Heliyon; 2023 Dec; 9(12):e22468. PubMed ID: 38107298
[TBL] [Abstract][Full Text] [Related]
2. Performance of Thyroid-Stimulating Immunoglobulin Bioassay and Thyrotropin-Binding Inhibitory Immunoglobulin Assay for the Diagnosis of Graves' Disease in Patients With Active Thyrotoxicosis.
Silva de Morais N; Angell TE; Ahmadi S; Alexander EK; Dos Santos Teixeira PF; Marqusee E
Endocr Pract; 2022 May; 28(5):502-508. PubMed ID: 35091101
[TBL] [Abstract][Full Text] [Related]
3. Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.
Woo YJ; Jang SY; Lim TH; Yoon JS
Korean J Ophthalmol; 2015 Aug; 29(4):213-9. PubMed ID: 26240504
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease.
Stan MN; Algeciras-Schimnich A; Murthy V; Thapa P; Araki N
Thyroid; 2022 Feb; 32(2):170-176. PubMed ID: 34714163
[No Abstract] [Full Text] [Related]
5. Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism.
Liu T; Zhang X; Long L; Zhou L; Chen J; Li M; Gao Y; Zhou X; Han X; Ji L
BMC Endocr Disord; 2022 Aug; 22(1):218. PubMed ID: 36045442
[TBL] [Abstract][Full Text] [Related]
6. Relevance of TSH-receptor antibody levels in predicting disease course in Graves' orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassay.
Jang SY; Shin DY; Lee EJ; Lee SY; Yoon JS
Eye (Lond); 2013 Aug; 27(8):964-71. PubMed ID: 23743527
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
Morris JC; Hay ID; Nelson RE; Jiang NS
Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the diagnostic performance of thyroid-stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease.
Xu S; Shao W; Wu Q; Zhu J; Pan B; Wang B; Guo W
J Clin Lab Anal; 2023 Apr; 37(8):e24890. PubMed ID: 37161617
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of thyroid-stimulating immunoglobulins in graves' ophthalmopathy.
Ponto KA; Kanitz M; Olivo PD; Pitz S; Pfeiffer N; Kahaly GJ
Ophthalmology; 2011 Nov; 118(11):2279-85. PubMed ID: 21684605
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of a chimeric TSH receptor (Mc4)-based bioassay for Graves' disease.
Lee JI; Jang HW; Kim SK; Choi JY; Kim JY; Hur KY; Kim JH; Min YK; Chung JH; Kim SW
Korean J Intern Med; 2011 Jun; 26(2):179-86. PubMed ID: 21716594
[TBL] [Abstract][Full Text] [Related]
12. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.
Lytton SD; Ponto KA; Kanitz M; Matheis N; Kohn LD; Kahaly GJ
J Clin Endocrinol Metab; 2010 May; 95(5):2123-31. PubMed ID: 20237164
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of thyroid-stimulating immunoglobulin detection for diagnosing Graves' disease and predictors of responsiveness to methimazole.
Liu K; Fu Y; Li T; Liu S; Chen D; Zhao C; Shi Y; Cai Y; Yang T; Zheng X
Clin Biochem; 2021 Nov; 97():34-40. PubMed ID: 34331946
[TBL] [Abstract][Full Text] [Related]
14. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between thyroid stimulating immunoglobulins and thyrotropin binding inhibitory immunoglobulins levels in patients with Graves' disease].
Jonas M; Ambroziak U; Nauman J
Endokrynol Pol; 2006; 57(1):23-30. PubMed ID: 16575759
[TBL] [Abstract][Full Text] [Related]
16. POSITIVE THYROTROPIN RECEPTOR ANTIBODIES IN PATIENTS WITH TRANSIENT THYROTOXICOSIS.
Angell TE; Van Benschoten O; Cohen DA; Haas AV; Alexander EK; Marqusee E
Endocr Pract; 2018 Jun; 24(6):512-516. PubMed ID: 29624097
[TBL] [Abstract][Full Text] [Related]
17. Correlation between TSH receptor antibody assays and clinical manifestations of Graves' orbitopathy.
Jang SY; Shin DY; Lee EJ; Choi YJ; Lee SY; Yoon JS
Yonsei Med J; 2013 Jul; 54(4):1033-9. PubMed ID: 23709442
[TBL] [Abstract][Full Text] [Related]
18. Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves' Orbitopathy.
Khamisi S; Lundqvist M; Engström BE; Larsson A; Karlsson FA; Ljunggren Ö
Exp Clin Endocrinol Diabetes; 2023 Apr; 131(4):236-241. PubMed ID: 36706788
[TBL] [Abstract][Full Text] [Related]
19. THYROTROPIN-RECEPTOR ANTIBODIES, IMMUNOGLOBULIN E AND ANTINUCLEAR ANTIBODIES IN PATIENTS WITH GRAVES' DISEASE AND GRAVES' ORBITOPATHY.
Stoynova M; Shinkov A; Kirilov G; Kovatcheva R
Acta Endocrinol (Buchar); 2021; 17(2):194-199. PubMed ID: 34925567
[TBL] [Abstract][Full Text] [Related]
20. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
